Health · 5 views
First-of-its-kind trial tests low-dose radiation to target brain inflammation in Parkinson's disease
Mayo Clinic researchers are studying whether low-dose radiation therapy can slow the progression of Parkinson's disease by targeting inflammation in areas of the brain affected by the disease.
AI Summary
Mayo Clinic researchers have launched the first clinical trial to test low‑dose radiation therapy as an anti‑inflammatory treatment for Parkinson’s disease. The study focuses on patients with early‑stage Parkinson’s, aiming to see whether targeted radiation can slow disease progression by reducing inflammation in affected brain regions. Researchers will monitor participants for changes in neurological symptoms and inflammatory markers as the trial proceeds.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- More people now use GLP-1s to lose weight than for other health issuesContinue reading
- Discrimination fuels mental health crisis among LGBTQ+ youth, national report findsContinue reading
- Donating a Kidney Could Lead to Later Pregnancy ComplicationsContinue reading
- Child health in England at risk from sharp rise in NHS waiting times, report saysContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow